Issue 10 | Fall
Five more years, three new protocols, two Co-PIs and one amazing consortium with the shared goal of improving the lives of people living with primary immunodeficiencies. This grant cycle, we introduce Primary Immune Regulatory Disorders (PIRD) to our list of diseases studied and look forward to collaborating with our partners at the newly funded Cincinnati DMCC.